Study to Compare Contrast-Enhanced Ultrasound, Contrast-Enhanced Dual Energy Mammography, and Contrast-Enhanced Breast MR for Early Breast Cancer Detection

Overview

Información sobre este estudio

The purpose of this study is to determine whether contrast-enhanced ultrasound (CEUS) can be used in diagnostic evaluation of breast lesions that cannot be seen using contrast-enhanced MRI (CEMR) and contrast- enhanced dual energy mammography (CEDM).   If so, patients can undergo US guided biopsy which is more comfortable for patients and more cost effective.

Elegibilidad para la participación

Los requisitos de elegibilidad de los participantes incluyen la edad, el sexo, el tipo y el estadio de la enfermedad, y los problemas de salud o tratamientos previos. Las pautas difieren de un estudio a otro e identifican quiénes pueden o no pueden participar. No hay garantía de que cada persona elegible que desee participar en un ensayo se inscribirá. Comunícate con el equipo del estudio para analizar la elegibilidad del estudio y la posible participación.

Inclusion Criteria:

  • Provision of signed and dated informed consent form.
  • Stated willingness to comply with all study procedures and availability for the duration of the study.
  • Patients, greater than 30 years of age.
  • In good general health as evidenced by medical history.
  • BIRADS 4 or 5 suspicious breast lesions who are scheduled for breast biopsy.

Exclusion Criteria:

  • Patients who are less than 30 years of age.
  • Have known or suspected cardiac shunts.
  • Have history of hypersensitive allergic reactions to any imaging contrast agents.
  • Pregnant (a urine pregnancy test will be given at no cost to the patient).
  • Are nursing babies.
  • Poor renal function.
  • Are unwilling or unable (such as having a pacemaker) to undergo a CEMR.

 

More information

Publicaciones

Publications are currently not available
.
CLS-20449460

Mayo Clinic Footer